Fertility News and Research

RSS

Study examines fundamental aspects of fertility in yeast

Research at the University of Leicester analyzing common Baking and Brewers yeast is providing new insights into aspects of human health and fertility.

27 Nov 2009

Scientists offer first genetic proof of new and rational treatment for osteoporosis

The so-called RANK protein and the molecule that binds to it, the RANK ligand or RANKL, form a focus of the work of Josef Penninger, director of the Institute of Molecular Biotechnology (IMBA) in Vienna. In 1999 his group deleted the RANKL gene from mice and showed that the RANK/RANKL system was the "master regulator" governing bone loss (Kong et al. 1999 Nature 402, 304-309).

26 Nov 2009

CHMP positive opinion for marketing ELONVA in Europe

PROLOR Biotech, Inc., today noted the positive opinion by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency for marketing approval in Europe for ELONVA(R), a long-acting CTP-modified version of the fertility hormone FSH from Merck & Co. Merck and PROLOR are both licensees of the CTP technology from Washington University in St. Louis.

25 Nov 2009

Hamilton Thorne announces financial results for third-quarter 2009

Hamilton Thorne Ltd., formerly Calotto Capital Inc., a leading provider of advanced laser systems and instruments for the stem cell research and fertility clinic markets, today reported operational and financial results for the third quarter ended September 30, 2009

24 Nov 2009

U.S. Court rules in Merck's favor in Flemings case involving FOSAMAX

Merck said today that U.S. District Court Judge John F. Keenan granted summary judgment in Merck's favor in Flemings v. Merck. Flemings is the second of three cases involving FOSAMAX (alendronate sodium) designated by the federal MDL court as a bellwether trial case.

24 Nov 2009

EMEA's CHMP recommends approval of Merck's ELONVA

Merck & Co., Inc. today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMEA) has recommended approval of ELONVA® (corifollitropin alfa injection) as a treatment in controlled ovarian stimulation (COS) in combination with a GnRH antagonist for the development of multiple follicles in women participating in an assisted reproductive technology (ART) program.

20 Nov 2009

IVF FLORIDA and Springstone to provide new financing options for fertility treatments

IVF FLORIDA Reproductive Associates today announced their partnership with Springstone Financial LLC to provide patients with improved financing options to fund IVF procedures and certain other fertility treatments. Financing programs are available to IVF FLORIDA and all IntegraMed Fertility Network patients immediately.

19 Nov 2009

Northeast Assisted Fertility Group opens new office in Atlanta

The Northeast Assisted Fertility Group (NAFG), already the leading surrogacy and egg donation program in Boston and New York, is pleased to announce the opening of a new office that will expand its services and resources to all its clients in the Atlanta area.

19 Nov 2009

Annual conference to discuss male infertility and tackling falling birth rates across Europe

Male infertility and tackling falling birth rates across Europe will be among the topics addressed at this year's British Andrology Society's annual conference at Queen's University in Belfast.

19 Nov 2009

VINNOVA to provide SEK 3.6 million for Vitrolife’s stem-cell research

Vitrolife: VINNOVA announced in a press release yesterday that they are going to provide support of SEK 3.6 million for Vitrolife’s research project for optimized culture media to enable the clinical use of stem cells. “It is very pleasing news and will enable more intensive work in an area that we very much believe in for the future”, says Magnus Nilsson, Vitrolife’s CEO.

18 Nov 2009

Gene therapy may hold promise for cryptorchid individuals risking infertility

EGR4 is a master gene responsible for fertility in cryptorchidism. Is gene therapy going to replace surgery?

18 Nov 2009

New proposal can have substantial implications on EU fertility treatment costs

With 900,000 assisted reproduction treatments annually such as IVF and intrauterine inseminations in Europe the Commission's proposal to screen both partners before each treatment could lead to costs of over EUR 140 million annually.

17 Nov 2009

U.S. again scores 'D' for premature birth rate; states take action to reduce risk factors

For the second consecutive year, the United States earned only a "D" on the March of Dimes Premature Birth Report Card, demonstrating that more than half a million of our nation's newborns didn't get the healthy start they deserved.

17 Nov 2009

Genentech submits sBLAs to the FDA for Avastin

Genentech, Inc., a wholly-owned member of the Roche Group, today announced that the company submitted two supplemental Biologics License Applications (sBLAs) to the U.S. Food and Drug Administration (FDA) for Avastin® (bevacizumab) for the treatment of women who have not received chemotherapy for advanced (metastatic) HER2-negative breast cancer (first-line treatment). One sBLA is based on the Phase III study AVADO that investigated Avastin in combination with docetaxel chemotherapy.

17 Nov 2009

Erbitux recognized as one of the major clinical cancer advances of 2009

The American Society of Clinical Oncology (ASCO) has once again recognized Erbitux® (cetuximab) as one of the major clinical cancer advances of 2009. This year Erbitux was selected by ASCO for providing the first significant increase in survival for 30 years in the treatment of patients with 1st-line recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCCHN).

16 Nov 2009

Alternative proposal from HSPH to AAFP for developing web content on beverages

Leading Harvard School of Public Health (HSPH) nutrition and health researcher Walter Willett, M.D., Dr. P.H., has written a letter to the President-elect of the American Academy of Family Physicians (AAFP) offering an alternative to the organization's decision, announced in October, to accept a six-figure grant from the Coca-Cola Company to develop web content on beverages and maintaining a healthy lifestyle.

13 Nov 2009

Breast cancer patients who undergo fertility preservation need not delay treatment

A new study published in the November issue of the Journal of the American College of Surgeons shows that breast cancer patients under 40 years old who undergo fertility preservation do not face a significant delay in the treatment of their disease when their care is coordinated in a timely fashion.

13 Nov 2009

HIV/AIDS leading cause of death among women ages 15-44, WHO study shows

In follow-up coverage to the WHO's report on women's health, several news outlets examine the impact HIV/AIDS is having on women around the world. "In its first study of women's health, the World Health Organization said yesterday that the AIDS virus is the leading cause of death and disease among women between the ages of 15 and 44," the Associated Press/Boston Globe reports (11/10).

11 Nov 2009

"Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads" report from MarketResearch.com

MarketResearch.com has announced the addition of Kalorama Information's new report "Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads," to their collection of In Vitro Diagnostics market reports.

10 Nov 2009

Study reveals that male factor infertility is associated with a number of medical comorbidities

The December issue of European Urology, the official journal of the European Association of Urology, features an article entitled 'Are Infertile Men Less Healthy than Fertile Men? Results of a Prospective Case-Control Survey' by Dr. Andrea Salonia et al. The conclusion is that male factor infertility is associated with a number of medical comorbidities, as objectively scored with the hospital-based Charlson Comorbidity Index.

10 Nov 2009

Fertility News and Research

Study examines fundamental aspects of fertility in yeast

Scientists offer first genetic proof of new and rational treatment for osteoporosis

CHMP positive opinion for marketing ELONVA in Europe

Hamilton Thorne announces financial results for third-quarter 2009

U.S. Court rules in Merck's favor in Flemings case involving FOSAMAX

EMEA's CHMP recommends approval of Merck's ELONVA

IVF FLORIDA and Springstone to provide new financing options for fertility treatments

Northeast Assisted Fertility Group opens new office in Atlanta

Annual conference to discuss male infertility and tackling falling birth rates across Europe

VINNOVA to provide SEK 3.6 million for Vitrolife’s stem-cell research

Gene therapy may hold promise for cryptorchid individuals risking infertility

New proposal can have substantial implications on EU fertility treatment costs

U.S. again scores 'D' for premature birth rate; states take action to reduce risk factors

Genentech submits sBLAs to the FDA for Avastin

Erbitux recognized as one of the major clinical cancer advances of 2009

Alternative proposal from HSPH to AAFP for developing web content on beverages

Breast cancer patients who undergo fertility preservation need not delay treatment

HIV/AIDS leading cause of death among women ages 15-44, WHO study shows

"Point of Care Diagnostics 2010 and Beyond: Rapid Testing at a Crossroads" report from MarketResearch.com

Study reveals that male factor infertility is associated with a number of medical comorbidities

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News